Patents by Inventor Axel Niclas Petri

Axel Niclas Petri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DRUG-DEVICE UNIT CONTAINING QUINAGOLIDE
    Publication number: 20220040094
    Abstract: The present invention is based on the identification of a cohort of polyurethane block copolymers that are particularly suited for use in pharmaceutical polymeric drug-device units and which offer improved control of drug release. In particular, there is provided a polymeric drug-device unit comprising a polyurethane block copolymer obtainable by reacting together a poly(alkylene oxide); a difunctional compound; a difunctional isocyanate; and optionally a block copolymer comprising poly(alkylene oxide) blocks; and quinagolide as a pharmaceutically active agent. The drug-device units may find application in the treatment and/or prevention of endometriosis.
    Type: Application
    Filed: May 10, 2021
    Publication date: February 10, 2022
    Applicant: Ferring B.V.
    Inventors: Janet Anne HALLIDAY, Denis Andrew CARR, Alistair Chassels ROSS, Claire Donaldson YOUNG, Paul MCDONALD, Mohammad Siddique QADIR, Robert Victor COCHRANE, Gouher RABANI, Joan Carles ARCE SAEZ, Axel Niclas PETRI
  • Drug-Device Unit Containing Quinagolide
    Publication number: 20180008535
    Abstract: The present invention is based on the identification of a cohort of polyurethane block copolymers that are particularly suited for use in pharmaceutical polymeric drug-device units and which offer improved control of drug release. In particular, there is provided a polymeric drug-device unit comprising a polyurethane block copolymer obtainable by reacting together a poly(alkylene oxide); a difunctional compound; a difunctional isocyanate; and optionally a block copolymer comprising poly(alkylene oxide) blocks; and quinagolide as a pharmaceutically active agent. The drug-device units may find application in the treatment and/or prevention of endometriosis.
    Type: Application
    Filed: November 5, 2015
    Publication date: January 11, 2018
    Inventors: Janet Anne Halliday, Denis Andrew Carr, Alistair Chassels Ross, Claire Donaldson Young, Paul McDonald, Mohammad Siddique Qadir, Robert Victor Cochrane, Gouher Rabani, Joan Carles Arce Saez, Axel Niclas Petri
  • COMPOSITION FOR THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA
    Publication number: 20120172302
    Abstract: The present disclosure is directed to compositions and kits comprising degarelix or a pharmaceutically acceptable salt thereof for the treatment of benign prostate hyperplasia (BPH), methods for treating BPH, and methods for preparing compositions of degarelix or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 5, 2010
    Publication date: July 5, 2012
    Inventors: Axel Niclas Petri, Lars Erichsen
  • COMPOSITIONS, KITS AND METHODS FOR TREATING BENIGN PROSTATE HYPERPLASIA
    Publication number: 20110039787
    Abstract: The present disclosure is directed to compositions and kits comprising degarelix or a pharmaceutically acceptable salt thereof for the treatment of benign prostate hyperplasia (BPH), methods for treating BPH, and methods for preparing compositions of degarelix or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: July 2, 2010
    Publication date: February 17, 2011
    Inventors: Axel Niclas Petri, Lars Erichsen